170 related articles for article (PubMed ID: 32439481)
1. Assessment of polymyxin B-doxycycline in combination against Pseudomonas aeruginosa in vitro and in a mouse model of acute pneumonia.
Gaurav A; Kothari A; Omar BJ; Pathania R
Int J Antimicrob Agents; 2020 Jul; 56(1):106022. PubMed ID: 32439481
[TBL] [Abstract][Full Text] [Related]
2. Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosa.
Lin YW; Yu HH; Zhao J; Han ML; Zhu Y; Akter J; Wickremasinghe H; Walpola H; Wirth V; Rao GG; Forrest A; Velkov T; Li J
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632010
[TBL] [Abstract][Full Text] [Related]
3. Polymyxin B and ethylenediaminetetraacetic acid act synergistically against
Hale SJM; Cameron AJ; Lux CA; Biswas K; Kim R; O'Carroll M; Harris PWR; Douglas RG; Wagner Mackenzie B
Microbiol Spectr; 2024 Feb; 12(2):e0170923. PubMed ID: 38168683
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice.
Kirby BD; Al Ahmar R; Withers TR; Valentine ME; Valentovic M; Long TE; Gaskins JR; Yu HD
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010865
[No Abstract] [Full Text] [Related]
6. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
[TBL] [Abstract][Full Text] [Related]
7. Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
Lin YW; Zhou Q; Onufrak NJ; Wirth V; Chen K; Wang J; Forrest A; Chan HK; Li J
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559256
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa.
Berditsch M; Jäger T; Strempel N; Schwartz T; Overhage J; Ulrich AS
Antimicrob Agents Chemother; 2015 Sep; 59(9):5288-96. PubMed ID: 26077259
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of silver nanoparticles and polymyxin B against biofilm produced by
Salman M; Rizwana R; Khan H; Munir I; Hamayun M; Iqbal A; Rehman A; Amin K; Ahmed G; Khan M; Khan A; Amin FU
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2465-2472. PubMed ID: 31187657
[No Abstract] [Full Text] [Related]
10. An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.
Schneider EK; Azad MA; Han ML; Tony Zhou Q; Wang J; Huang JX; Cooper MA; Doi Y; Baker MA; Bergen PJ; Muller MT; Li J; Velkov T
ACS Infect Dis; 2016 Jul; 2(7):478-88. PubMed ID: 27626100
[TBL] [Abstract][Full Text] [Related]
11. Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia.
Louie A; Liu W; VanGuilder M; Neely MN; Schumitzky A; Jelliffe R; Fikes S; Kurhanewicz S; Robbins N; Brown D; Baluya D; Drusano GL
J Infect Dis; 2015 Apr; 211(8):1326-33. PubMed ID: 25362196
[TBL] [Abstract][Full Text] [Related]
12. Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection.
Omri A; Suntres ZE; Shek PN
Biochem Pharmacol; 2002 Nov; 64(9):1407-13. PubMed ID: 12392822
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol Increases Sensitivity of Clinical Colistin-Resistant Pseudomonas aeruginosa to Colistin
Wang L; Zhang Y; Lin Y; Cao J; Xu C; Chen L; Wang Y; Sun Y; Zheng X; Liu Y; Zhou T
Microbiol Spectr; 2023 Feb; 11(1):e0199222. PubMed ID: 36475724
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
Li Y; Huang J; Li L; Liu L
Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
[TBL] [Abstract][Full Text] [Related]
16. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T
ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483
[TBL] [Abstract][Full Text] [Related]
17. Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones.
Montero MM; Domene Ochoa S; López-Causapé C; VanScoy B; Luque S; Sorlí L; Campillo N; Padilla E; Prim N; Segura C; Pomar V; Rivera A; Grau S; Ambrose PG; Oliver A; Horcajada JP
J Glob Antimicrob Resist; 2019 Sep; 18():37-44. PubMed ID: 31154007
[TBL] [Abstract][Full Text] [Related]
18. Nebulized Amikacin and Fosfomycin for Severe Pseudomonas aeruginosa Pneumonia: An Experimental Study.
Li Bassi G; Motos A; Fernandez-Barat L; Aguilera Xiol E; Chiurazzi C; Senussi T; Saco MA; Fuster C; Carbonara M; Bobi J; Amaro R; De Rosa F; Comaru T; Yang H; Ranzani OT; Marti JD; Rinaudo M; Comino Trinidad O; Rigol M; Bringué J; Ramirez J; Nicolau DP; Pelosi P; Antonelli M; Blasi F; Artigas A; Montgomery AB; Torres A
Crit Care Med; 2019 Jun; 47(6):e470-e477. PubMed ID: 30882478
[TBL] [Abstract][Full Text] [Related]
19. Activities of tobramycin and polymyxin E against Pseudomonas aeruginosa biofilm-coated medical grade endotracheal tubes.
Tarquinio K; Confreda K; Shurko J; LaPlante K
Antimicrob Agents Chemother; 2014; 58(3):1723-9. PubMed ID: 24379207
[TBL] [Abstract][Full Text] [Related]
20. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
Konai MM; Haldar J
ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
